Cargando…
Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer’s Disease
The phosphoinositide phosphatase synaptojanin 1 (SYNJ1) is a key regulator of synaptic function. We first tested whether SYNJ1 contributes to phenotypic variations in familial Alzheimer’s disease (FAD) and show that SYNJ1 polymorphisms are associated with age of onset in both early- and late-onset h...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040810/ https://www.ncbi.nlm.nih.gov/pubmed/29874583 http://dx.doi.org/10.1016/j.celrep.2018.05.011 |
_version_ | 1783338894206435328 |
---|---|
author | Miranda, Andre M. Herman, Mathieu Cheng, Rong Nahmani, Eden Barrett, Geoffrey Micevska, Elizabeta Fontaine, Gaelle Potier, Marie-Claude Head, Elizabeth Schmitt, Frederick A. Lott, Ira T. Jiménez-Velázquez, Ivonne Z. Antonarakis, Stylianos E. Paolo, Gilbert Di Lee, Joseph H. Hussaini, S. Abid Marquer, Catherine |
author_facet | Miranda, Andre M. Herman, Mathieu Cheng, Rong Nahmani, Eden Barrett, Geoffrey Micevska, Elizabeta Fontaine, Gaelle Potier, Marie-Claude Head, Elizabeth Schmitt, Frederick A. Lott, Ira T. Jiménez-Velázquez, Ivonne Z. Antonarakis, Stylianos E. Paolo, Gilbert Di Lee, Joseph H. Hussaini, S. Abid Marquer, Catherine |
author_sort | Miranda, Andre M. |
collection | PubMed |
description | The phosphoinositide phosphatase synaptojanin 1 (SYNJ1) is a key regulator of synaptic function. We first tested whether SYNJ1 contributes to phenotypic variations in familial Alzheimer’s disease (FAD) and show that SYNJ1 polymorphisms are associated with age of onset in both early- and late-onset human FAD cohorts. We then interrogated whether SYNJ1 levels could directly affect memory. We show that increased SYNJ1 levels in autopsy brains from adults with Down syndrome (DS/AD) are inversely correlated with synaptophysin levels, a direct readout of synaptic integrity. We further report age-dependent cognitive decline in a mouse model overexpressing murine Synj1 to the levels observed in human sporadic AD, triggered through hippocampal hyperexcitability and defects in the spatial reproducibility of place fields. Taken together, our findings suggest that SYNJ1 contributes to memory deficits in the aging hippocampus in all forms of AD. |
format | Online Article Text |
id | pubmed-6040810 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-60408102018-07-11 Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer’s Disease Miranda, Andre M. Herman, Mathieu Cheng, Rong Nahmani, Eden Barrett, Geoffrey Micevska, Elizabeta Fontaine, Gaelle Potier, Marie-Claude Head, Elizabeth Schmitt, Frederick A. Lott, Ira T. Jiménez-Velázquez, Ivonne Z. Antonarakis, Stylianos E. Paolo, Gilbert Di Lee, Joseph H. Hussaini, S. Abid Marquer, Catherine Cell Rep Article The phosphoinositide phosphatase synaptojanin 1 (SYNJ1) is a key regulator of synaptic function. We first tested whether SYNJ1 contributes to phenotypic variations in familial Alzheimer’s disease (FAD) and show that SYNJ1 polymorphisms are associated with age of onset in both early- and late-onset human FAD cohorts. We then interrogated whether SYNJ1 levels could directly affect memory. We show that increased SYNJ1 levels in autopsy brains from adults with Down syndrome (DS/AD) are inversely correlated with synaptophysin levels, a direct readout of synaptic integrity. We further report age-dependent cognitive decline in a mouse model overexpressing murine Synj1 to the levels observed in human sporadic AD, triggered through hippocampal hyperexcitability and defects in the spatial reproducibility of place fields. Taken together, our findings suggest that SYNJ1 contributes to memory deficits in the aging hippocampus in all forms of AD. 2018-06-05 /pmc/articles/PMC6040810/ /pubmed/29874583 http://dx.doi.org/10.1016/j.celrep.2018.05.011 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Miranda, Andre M. Herman, Mathieu Cheng, Rong Nahmani, Eden Barrett, Geoffrey Micevska, Elizabeta Fontaine, Gaelle Potier, Marie-Claude Head, Elizabeth Schmitt, Frederick A. Lott, Ira T. Jiménez-Velázquez, Ivonne Z. Antonarakis, Stylianos E. Paolo, Gilbert Di Lee, Joseph H. Hussaini, S. Abid Marquer, Catherine Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer’s Disease |
title | Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer’s Disease |
title_full | Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer’s Disease |
title_fullStr | Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer’s Disease |
title_full_unstemmed | Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer’s Disease |
title_short | Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer’s Disease |
title_sort | excess synaptojanin 1 contributes to place cell dysfunction and memory deficits in the aging hippocampus in three types of alzheimer’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040810/ https://www.ncbi.nlm.nih.gov/pubmed/29874583 http://dx.doi.org/10.1016/j.celrep.2018.05.011 |
work_keys_str_mv | AT mirandaandrem excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT hermanmathieu excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT chengrong excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT nahmanieden excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT barrettgeoffrey excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT micevskaelizabeta excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT fontainegaelle excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT potiermarieclaude excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT headelizabeth excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT schmittfredericka excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT lottirat excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT jimenezvelazquezivonnez excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT antonarakisstylianose excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT paologilbertdi excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT leejosephh excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT hussainisabid excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease AT marquercatherine excesssynaptojanin1contributestoplacecelldysfunctionandmemorydeficitsintheaginghippocampusinthreetypesofalzheimersdisease |